Legal Affairs
Verano Reports Q1 2026 Financial Results
CHICAGO – Verano Holdings Corp. released its financial results for the three months ended March 31, 2026, showing revenue largely in line with recent quarters as the multi-state Cannabis operator managed wholesale pressures while leaning ...
SNDL Reports Q1 2026 Financial and Operational Results
EDMONTON – SNDL Inc. disclosed a 4.4% drop in net revenue for the three months ended March 31, 2026, as softness in both its Cannabis and liquor businesses weighed on results. The company, which operates ...
Hemp THC Ban Moves Closer as Congressional Fixes Collapse
WASHINGTON – The federal clock on hemp-derived THC products is ticking with no sign of relief from Capitol Hill. Amendments filed last week to delay, or in one case accelerate, the November 12 ban on ...
Oklahoma Law Review Claims 280E No Longer Applies Post-Cannabis Rescheduling
TULSA – A forthcoming article in the Oklahoma Law Review contends that federal rescheduling of Cannabis to Schedule III would place the plant outside the reach of Internal Revenue Code Section 280E, potentially ending the ...
LEEF Brands Reaches Deal to Acquire Himalaya Vapor
VANCOUVER – LEEF Brands Inc. entered into an agreement and plan of merger to acquire Standard Holdings Inc. the parent company of Himalaya Vapor, a California concentrates producer known for its full-spectrum cartridges and live ...
ATACH Publishes Report on Updated Hemp Regulations
WASHINGTON – Federal lawmakers moved last year to shut down a major loophole in hemp rules, and the American Trade Association for Cannabis and Hemp (ATACH) has now delivered a clear-eyed examination outlining the regulatory ...
Seed Junky Genetics Announces MINNTZ Return
LOS ANGELES – JBeezy, the founder of Seed Junky Genetics, confirmed that the MINNTZ® brand is officially returning as an independent line following a new agreement with Michigan-based HNG Solutions, LLC. The partnership will put ...
Verano Reports Q1 2026 Financial Results
CHICAGO – Verano Holdings Corp. released its financial results for the three months ended March 31, 2026, showing revenue largely in line with recent quarters as the multi-state Cannabis operator managed wholesale pressures while leaning ...
SNDL Reports Q1 2026 Financial and Operational Results
EDMONTON – SNDL Inc. disclosed a 4.4% drop in net revenue for the three months ended March 31, 2026, as softness in both its Cannabis and liquor businesses weighed on results. The company, which operates ...
Hemp THC Ban Moves Closer as Congressional Fixes Collapse
WASHINGTON – The federal clock on hemp-derived THC products is ticking with no sign of relief from Capitol Hill. Amendments filed last week to delay, or in one case accelerate, the November 12 ban on ...
Conservative Think Tank Advocates Federal Cannabis Labeling Standards to Address State Disparities
WASHINGTON – A prominent conservative policy group has called for federal guidance on Cannabis product warnings, pointing to stark differences in state regulations that leave consumers with inconsistent information on health risks. The American Enterprise ...
Psyence BioMed Ventures into Psilocybin’s Role in Aging Research
NEW YORK – Psyence BioMedical Ltd. disclosed its entry into longevity science with a new program probing psilocybin's influence on key aging indicators. The initiative, conducted alongside South African academics, marks the company's first foray ...
Kenyan MP Advocates for Regulated Cannabis Framework
NAIROBI – Peter Kalerwa Salasya, the outspoken member of Parliament for Kenya's Mumias East constituency, has ignited fresh debate on Сannabis policy by urging the government to pursue legalization under strict controls. Salasya highlighted the ...
OPINION: The Looming Federal Clampdown on THC Drinks and Hemp-Derived Edibles: What It Means for the Industry
NEW YORK- The quiet addition of a single paragraph in November’s federal shutdown bill has sent shockwaves through one of the fastest-growing segments of U.S. Cannabis: hemp-derived THC beverages and edibles. Unless Congress intervenes, a ...
Tilray Executes 1-for-10 Reverse Stock Split to Trim Shares and Cut Costs
NEW YORK – Tilray Brands Inc. confirmed it will carry out a 1-for-10 reverse stock split on its common shares, a step shareholders greenlit back in June to help the company meet Nasdaq listing standards ...
New York State OCM Updates Medical Cannabis Program, Expands Access for Out-of-State Patients
ALBANY – Governor Kathy Hochul signed a bill into law that extends New York's medical Cannabis program to patients certified in other states, marking the most substantial revision to the initiative since its 2016 launch. ...
New Brunswick Government Bets on Organigram with $2M Grant
MONCTON – Organigram Global Inc. has secured $2 million in provincial funding to support a $9.3 million project aimed at revamping its flagship cultivation site here. The upgrade, which targets lighting systems across 75 grow ...
Jazz Pharmaceuticals: The Medical Cannabis Insider Nearing $1B Milestone
DUBLIN – Jazz Pharmaceuticals reported a 20% jump in Q3 2025 sales for its cannabidiol-based epilepsy drug Epidiolex®, pushing the product's YTD revenue past $772 million and underscoring the company's steady position in the medical ...
Medicare Explores CBD Coverage for Seniors
WASHINGTON – The Centers for Medicare & Medicaid Services (CMS) is set to roll out a pilot program that could extend coverage to cannabidiol (CBD) treatments for certain older Americans, marking a cautious step by ...
How to Make the Most of MJBizCon? Take Full Advantage of LinkedIn
LOS ANGELES- Each year, the global Cannabis industry converges on Las Vegas for MJBizCon Dec 2-5 in the Las Vegas Convention Center—a concentrated, high-value moment where operators, investors, executives, retailers, lenders, lawyers, accountants, manufacturers, and ...
New Jersey Assembly Panel Clears Path for Psilocybin Therapy Program
TRENTON – New Jersey lawmakers advanced a bill that would allow supervised access to psilocybin for adults facing certain health challenges, establishing a regulated psilocybin therapy framework approved by the Assembly Health Committee. Assemblymember Anthony ...
Week in Review: Cannabis & Psychedelics Industry Highlights
LOS ANGELES – Operators and investors in Cannabis and Psychedelics faced a week of sharp contrasts. Federal action ended the longest government shutdown on record, yet it delivered a body blow to hemp-derived products that ...
Europe Advances Psychedelic Medicine with Targeted Approvals in Three Nations
BERLIN – Switzerland's long-standing framework for psychedelic treatments has set a course for its neighbors, as Germany and the Czech Republic roll out their own programs to address stubborn mental health conditions. These steps mark ...
Tilray Updated Investor Presentation Detailing Diversification Strategy
NEW YORK – Tilray Brands Inc. laid out its broadened ambitions in a new Investor Presentation. The document maps a course for the company to solidify its place as a consumer goods player, blending Cannabis ...
Argent BioPharma Secures AU$11M Facility to Finalize AusCann Assets Purchase
SYDNEY – Argent BioPharma Ltd., a developer of cannabinoid-based treatments for neurological disorders, has arranged an AU$11 million convertible debt facility to close its pending acquisition of key assets from the defunct AusCann Group Holdings ...
West Virginia Medical Cannabis Costs Drive Patients Across State Lines for Lower-Priced Options
CHARLESTON – Elevated prices in West Virginia's medical Cannabis system continue to steer registered patients toward recreational outlets in Ohio, Maryland, and Michigan, where products sell at fractions of the cost despite legal barriers to ...
Florida Takes Action to Advance Adult-Use Cannabis Ballot Measure, Lawsuit Ends Delay
TALLAHASSEE – Florida election officials cleared a procedural roadblock for a proposed constitutional amendment to legalize recreational Cannabis, submitting the measure to the state attorney general's office just weeks after advocates sued over perceived delays ...
Viridian Capital Advisors Reports Valuation Metrics for U.S. MSOs with Market Caps >$100M
LOS ANGELES – Multi-state cannabis operators in the United States are carrying valuation multiples that signal caution among investors, even as growth prospects brighten for the coming year. According to a fresh Weekly Valuation Report ...
OPINION: Industrial hemp just got ‘future proofed.’
NEW YORK- Industrial hemp just received the clearest signal yet that it's not a fad, not a loophole, and not going away. It was effectively declared “future proof.” When Congress passed the funding bill to ...
EU Cannabis Imports Explained: Rules, Regulations, Safety & Quality Control
LOS ANGELES – Germany's medical Cannabis imports reached 56.9 tons in Q3 2025, a 19% jump from the prior period and a fresh record that highlights the market's relentless pull. With an estimated 900k prescriptions ...
Gallup Reveals First Dip in Years for Cannabis Legalization Public Support
LOS ANGELES – A fresh Gallup survey reveals that 64% of American adults now back making Cannabis use legal, a figure that marks the first decline in overall support since 2019 and pulls back from ...
New York Updates Cannabis Packaging, Labeling, and Advertising Regulations
NEW YORK – The New York State Cannabis Control Board finalized amendments to its packaging, labeling, marketing, and advertising regulations, marking a significant step in refining the state's adult-use Cannabis market. The changes aim to ...
Planet 13 Reports Q3 2025 Financial Results
LAS VEGAS – Planet 13 Holdings Inc., a multistate Cannabis operator with flagship operations in Nevada and Florida, disclosed a $44 million net loss for the third quarter, reflecting the toll of compressed prices, softening ...
Glass House Brands Reports Q3 2025 Financial Results
LONG BEACH – Glass House Brands Inc. disclosed third-quarter 2025 earnings that showed a marked slowdown in sales and profitability, chalked up to deliberate shifts in its labor strategy. The company posted revenue of $38.4 ...
ANTG Inks Deal with Curaleaf to Supply Medical Cannabis for UK Patients
LONDON – Australian Natural Therapeutics Group, a leading cultivator of pharmaceutical-grade Cannabis, has reached an agreement with Curaleaf Laboratories to bring its products to British patients, marking a cross-continental push into Europe's second-largest medical Cannabis ...
